Dr. J-D Schwalm

Division of Cardiology

J-D Schwalm

MD, MSc, FRCP(C)

Associate Professor, Division of Cardiology, Department of Medicine

Principal Investigator, Knowledge Translation Program, Population Health Research Institute

Interventional Cardiologist, Hamilton Health Sciences

 

 

 

Education and Professional Standing

Dr. Schwalm completed his honours Bachelor of Science degree with a specialization in Biomedical Sciences at the University of Guelph, Ontario. Medical school, internal medicine residency, and cardiology fellowship training were all completed at McMaster University, Ontario.  Subsequently, he has completed an interventional cardiology fellowship at McMaster University, and obtained further training in this field at the University of Ottawa, Heart Institute.  Dr. Schwalm is a fellow of the Royal College of Physicians and Surgeons of Canada, with certification in internal medicine and cardiology. 

Clinical Interests

Dr. Schwalm is a fulltime interventional cardiologist at Hamilton Health Sciences.  He is actively involved in postgraduate medical training of residents and fellows in invasive angiography, angioplasty, general cardiology, and internal medicine.

Research Interests

Dr. Schwalm completed a Master of Science in Epidemiology at the University of Ottawa.  He has a particular interest in knowledge translation, as it relates to the field of cardiology. He is Principal Investigator of two ongoing provincial and international randomized controlled trials. He has published over 50 peer-reviewed scientific papers, abstracts and book chapters.

Selected Funding

2014 HSRF Award: ISLAND-ACS: Province-wide RCT of interventions to support the long-term adherence to medications in patients post ACS (Co-PI) ($1,039,155 over 3 years)
2014 QUEST Fund: Benefits Of An ICD/CRT Smart Phone App For Physician Referrals and e-Health Education (ICD-CRT TEACH) (Supervisor, Co-PI) ($8000 over 1 year)
2014 CIHR Grant: HOPE-4: Cluster RCT of a model cardiovascular risk assessment, treatment and control programme in Canada(PI) ($100,000 over 1 year)
2014 World Heart Federation Funding Competition: TAKEMeds: The Adherence and Knowledge Exchange heart and stroke medicines study (Co-PI) ($49000)
2014 PHRI Internal Funding Competition: HOPE-4: Cluster RCT of a model cardiovascular risk assessment, treatment and control programme(PI) ($201741 over 3 year)
2013 KT Canada Research Stipend:Revascularization strategies in multi-vessel coronary artery disease: Analysis of influencing factors($6,000)
2010-2013 E.J. Moran Campbell AFP Internal Career Research Award ($30,000/year)
2012 New Investigator Fund: Clinically Observed Multivessel Revascularization: Agreement In Therapeutic Decisions Between Operator AndHeart Team($32,000)
2012 CIHR Team Grant: Implementation Research on Hypertension in Low and Middle IncomeCountries (co-applicant) ($1,500,000 over 5 years)

Selected Publications

  1. Schwalm JD, Ivers NM, Natarajan MK, Taljaard M, Rao-Melacini P, Witteman HO, Zwarenstein M, Grimshaw JM.  Cluster randomized controlled trial of Delayed Educational Reminders for Long-term Medication Adherence in ST-Elevation Myocardial Infarction (DERLA -STEMI). Am Heart J 2015;170:903-913.
  2. Risso-Gill I, Balabanova D, Majid F, Ng KK, Yusoff K, Mustapha F, Kuhlbrandt C, Nieuwlaat R, Schwalm JD, McCready T, Teo KK, Yusuf S, McKee M. Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach. BMC Health Serv Res 2015 Jul 3;15:254.
  3. Alazzoni A, Gordon CL, Syed J, Natarajan MK, Rokoss M, Schwalm JD, Mehta SR, Sheth T, Valettas N, Velianou J, Pandie S, Al Khdair D, Tsang M, Meeks B, Colbran K, Waller E, Fu Lee S, Marsden T, Jolly SS.  Randomized Controlled Trial of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap for Operators Performing Coronary Angiographyor Intervention. CircCardiovascInterv 2015;8(8):e002384.
  4. Jolly SS, Cairns JA, Yusuf S, Meeks B, Gao P, Hart RG, Kedev S, Stankovic G, Moreno R, Horak D, Kassam S, Rokoss MJ, Leung RC, El-Omar M, Romppanen HO, Alazzoni A, Alak A, Fung A, Alexopoulos D, Schwalm JD, Valettas N, Džavík V; TOTAL Investigators.Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. Eur Heart J. 2015 Sep 14;36(35):2364-72. [Epub2015 Jun 29].
  5. Gandhi S, Schwalm JD, Velianou JL, Natarajan MK, Farkouh ME.  Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy AfterTranscatheter Aortic ValveImplantation: Systematic Review and Meta-analysis.  Can J Cardiol 2015 Jun;31(6):775-84 [Epub 2015 Jan24].

  6. Legido-Quigley H, Camacho Lopez PA, Balabanova D, Perel P, Lopez-Jaramillo P, Nieuwlaat R, Schwalm JD, McCready T, Yusuf S, McKee M. Patients’ Knowledge, Attitudes, Behaviour and Health Care Experiences on the Prevention, Detection, Management and Control of Hypertension in Colombia: A Qualitative Study. PLoS ONE 2015;10(4): e0122112. doi:10.1371/journal.pone.0122112.
  7. Mercuri M,Welsford M, Schwalm JD, Mehta SR, Rao-Melacini P, Valettas N, Sheth T, Rokoss M, Jolly SS, Velianou JL, Natarajan MK.  Providing optimal regional care for ST-segment elevation myocardial infarction: a prospective cohort study of patients in the Hamilton Niagara Haldimand Brant Local Health Integration Network. CMAJ Open 2015;3(1):E1-7.  doi:10.9778/cmajo.20140035
  8. Schwalm JD, Wijeysundera HC, Tu JV, Guo H, Kingsbury KJ, Natarajan MK.  Influence of coronary anatomy and SYNTAX score on the variations in revascularization strategies for patients with multivessel disease.  Can J Cardiol. 2014;30(10):1155-61.doi:10.1016/j.cjca.2014.04.006. Epub 2014
  9. Khatib R, Schwalm JD, Khan M, McKee M, Haynes BR, Yusuf S, Nieuwlaat R. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: A systematic review and meta- analysis of qualitative and quantitative studies.  Plos One 2014;9(1):e84238.
  10. Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, Mente A, Nieuwlaat R, Pais P, Rodgers A, Schwalm JD, Smith R, Teo K, Xavier D. Working Group on the Summit on Combination Therapy for CVD.
    Combination Pharmacotherapy to Prevent CVD: Present Status and Challenges. Eur Heart J . 2014;35(6):353-64.doi: 10.1093/eurheartj/eht407. Epub 2013.
  11. Ivers N, Schwalm JD, Jackevicius C, Guo H, Tu JV, Natarajan MK.  Length of initial prescription at hospital discharge and long-term medication adherence for patients with coronary artery disease: a population-level retrospective cohort study. CJC 2013; 29(11): 1408-14.doi: 10.1016/j.cjca.2013.04.009. Epub 2013.
  12. Nieuwlaat R, Schwalm JD, Khatib R, Yusuf S. Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J. 2013;34(17):1262-9.doi: 10.1093/eurheartj/ehs481. Epub 2013.
  13. Ivers NM, Schwalm JD, Grimshaw JM, Witteman H, Taljaard M, Zwarenstein M, Natarajan MK. Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): Protocol for a pragmatic, cluster-randomized controlled trial. Implement Sci. 2012;7(1):54.  doi: 10.1186/1748-5908-7-54.
  14. Schwalm JD, Stacey D, Pericak D, Natarajan MK.  Radial Artery Versus Femoral Artery Access Options in Coronary Angiogram Procedures:Randomized Controlled Trial of A Patient Decision Aid.  Circulation: Cardiovascular Quality and Outcomes 2012;5(3):260-266.  doi: 10.1161/CIRCOUTCOMES.111.962837. Epub 2012
  15. Schwalm JD, Yusuf S.  Commentary: ‘The end of clinicalfreedom’: relevance in the era ofevidence-based medicine.  Int J ClinEpi 2011; 40(4): 855-858.doi: 10.1093/ije/dyr046. No abstract available.
  16. Schwalm JD, Ahmad M, Eikelboom JW, Natarajan MK.  A National Survey of Canadian Practice Patterns of Warfarin after Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy.Am J Cardiol. 2010;105(12):1844.doi: 10.1016/j.amjcard.2010.03.022. No abstract available.
  17. Jamula E, Lloyd NS, Schwalm JD, Airaksinen KE, Douketis JD. Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis. Chest. 2010 Oct;138(4):840-7.doi: 10.1378/chest.09-2603. Epub 2010.
  18. Schwalm JD, Ahmad M, Salehian O, Eikelboom JW, Natarajan MK.  Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: A randomized feasibility trial.Journal of Thrombosis and Thrombolysis 2010; 30(2):127-32.  doi: 10.1007/s11239-010-0448-6.
  19. Schwalm JD, Ahmad M, Velianou JL, Pericak D, Natarajan MK.  Long-term Clinical Outcomes with Paclitaxel-Eluting Stents versus Bare Metal Stents in Everyday Practice. Canadian Journal of Cardiology 2010;26(2):e40-e44.
  20. Jamula E, Schwalm JD, Douketis JD.  Periprocedural Anticoagulation Practices in Warfarin-treated Patients who require Elective Angiography with or without Percutaneous Coronary Intervention: A Retrospective Chart Review. Thrombosis Research 2010 Apr;125(4):351-2.doi: 10.1016/j.thromres.2009.10.015. Epub 2009.
  21. Schwalm JD, Teo KK.  Stable Angina: A Balanced Approach.  Heart Metabolism 2008;38:16-19.
  22. Ahmad M, Schwalm JD, Velianou JL, Pericak D, Natarajan MK.  Comparison of One Year Clinical Outcomes with Paclitaxel-Eluting Stents versus Bare Metal Stents in Everyday Canadian Practice. Canadian Journal of Cardiology 2008;24(10):771-775.
  23. Schwalm JD, Hamstra J, Mulji A, Velianou J.  Cardiogenic Shock Following Nasal Septoplasty; A Case Report and Review of the Literature.  Canadian Journal of Anesthesia 2008;55(6):376-9.doi: 10.1007/BF03021494.
  24. Schwalm JD, Ahmad M, Velianou JL, Xie C, Natarajan MK.  Primary and Rescue Percutaneous Coronary Intervention with Paclitaxel-Eluting Stent Implantation.  Am J Cardiol. 2006 May 1;97(9):1308-10. Epub 2006.